New Products In Brief
This article was originally published in The Gray Sheet
Sequenom’s Down syndrome test
You may also be interested in...
A drug-eluting stent and prostate cancer assay are among newly approved devices.
InSightec submits ExAblate PMA to treat pain caused by bone metastases. AngioDynamics initiates NanoKnife software recall. Sequenom raises $62 million in secondary stock offering. More news briefs.
Segasist expects FDA to decide as early as this month on a 510(k) submission for a prostate-contouring software system designed to "learn" as it goes and become more and more accurate the more it is used.